We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.19B
AUM Growth
+$101M
Cap. Flow
-$58.6M
Cap. Flow %
-1.84%
Top 10 Hldgs %
16.65%
Holding
340
New
17
Increased
56
Reduced
185
Closed
23

Top Buys

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$27.5M
2
UBER icon
Uber
UBER
+$20.6M
3
GDEN
Golden Entertainment
GDEN
+$10.5M
4
THS
Treehouse Foods
THS
+$10.1M
5
HBI
Hanesbrands
HBI
+$9.58M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$29.4M
2
AVLR
Avalara, Inc.
AVLR
+$29.4M
3
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
+$14.3M
4
META icon
Meta Platforms (Facebook)
META
+$12.9M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$12.9M

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Healthcare 18.05%
3 Financials 16.4%
4 Consumer Discretionary 13.46%
5 Industrials 11.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BV icon
226
BrightView Holdings
BV
$1.05B
$5.5M 0.17%
798,461
-8,659
-1% -$66.8K
OPLN
227
Openlane
OPLN
$4.48B
$5.48M 0.17%
419,680
-12,925
-3% -$173K
CDMO
228
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$5.46M 0.17%
396,604
-11,666
-3% -$179K
OSH
229
DELISTED
Oak Street Health, Inc.
OSH
$5.26M 0.16%
244,398
-7,571
-3% -$158K
VRAY
230
DELISTED
ViewRay, Inc.
VRAY
$5.2M 0.16%
1,161,462
-35,284
-3% -$153K
BLFS icon
231
BioLife Solutions
BLFS
$1.7B
$5.2M 0.16%
285,648
-8,646
-3% -$179K
MNRO icon
232
Monro
MNRO
$365M
$5.08M 0.16%
112,405
-3,407
-3% -$157K
GKOS icon
233
Glaukos
GKOS
$10.7B
$5.04M 0.16%
+115,452
New +$5.69M
IONS icon
234
Ionis Pharmaceuticals
IONS
$9.21B
$4.97M 0.16%
131,711
+8,315
+7% +$350K
PAR icon
235
PAR Technology
PAR
$721M
$4.82M 0.15%
185,017
-5,602
-3% -$144K
ZUO
236
DELISTED
Zuora, Inc.
ZUO
$4.5M 0.14%
707,656
-21,176
-3% -$150K
FORM icon
237
FormFactor
FORM
$9.46B
$4.36M 0.14%
196,037
-5,513
-3% -$128K
CLVT icon
238
Clarivate
CLVT
$1.22B
$4.32M 0.14%
518,063
+40,500
+8% +$380K
SWTX
239
DELISTED
SpringWorks Therapeutics
SWTX
$4.28M 0.13%
+164,541
New +$4.05M
NVCR icon
240
NovoCure
NVCR
$2.06B
$2.41M 0.08%
32,912
-7,918
-19% -$596K
ADPT icon
241
Adaptive Biotechnologies
ADPT
$4.04B
$2.04M 0.06%
267,631
-11,100
-4% -$86.4K
IOVA icon
242
Iovance Biotherapeutics
IOVA
$2.94B
$1.87M 0.06%
292,165
+50,671
+21% +$396K
DHR icon
243
Danaher
DHR
$146B
$1.61M 0.05%
6,838
– –
MANH icon
244
Manhattan Associates
MANH
$11.4B
$1.58M 0.05%
13,007
– –
BG icon
245
Bunge Global
BG
$21.4B
$1.57M 0.05%
15,707
– –
CGNX icon
246
Cognex
CGNX
$10.6B
$1.44M 0.05%
30,636
– –
WCC
247
WESCO International
WCC
$17.8B
$1.42M 0.04%
11,355
– –
CP icon
248
Canadian Pacific Kansas City
CP
$80.8B
$1.39M 0.04%
18,581
– –
NOVT icon
249
Novanta
NOVT
$6.34B
$1.38M 0.04%
10,181
– –
FSLR icon
250
First Solar
FSLR
$25.9B
$1.35M 0.04%
9,037
+2,600
+40% +$385K
8 9
10
11 12

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Peregrine Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Peregrine Capital Management held 340 positions worth $3.19B, up 3.3% from $3.09B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Peregrine Capital Management's Q4 2022 filing shows 17 new, 56 increased, 185 reduced and 23 closed positions. Its largest new stake was Snowflake: 180,455 shares worth $25.9M. The largest sale was Abiomed Inc, an estimated $29.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q4 2022 buy was Snowflake: 180,455 shares worth $25.9M.
  • Peregrine Capital Management added most to CrowdStrike in Q4 2022, an estimated $7.47M increase.
  • Peregrine Capital Management's biggest Q4 2022 reduction was EVO Payments, Inc. Class A Common Stock, cutting an estimated $14.3M.
  • Peregrine Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $29.4M.
  • Peregrine Capital Management's ten largest holdings make up 17% of its $3.19B portfolio in Q4 2022.
  • Peregrine Capital Management opened 17 new positions and closed 23 in Q4 2022.
  • Peregrine Capital Management's portfolio value rose 3.3% quarter-over-quarter to $3.19B.

Based on Peregrine Capital Management's 13F filing for Q4 2022, filed 10 Jan 2023.